Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Douglas

Showing results (91-100 of 122) with videos related to

Pageof 13
Sort By:
AIDS (London, England)|October 3, 2003
Phase I/II trial of intravenous recombinant interleukin-2 in HIV-infected childrenStuart E Starr, Elizabeth J McFarland, Petronella Muresan, et al.
Journal of Neurochemistry|February 27, 2003
Interleukin-1beta stimulates macrophage inflammatory protein-1alpha and -1beta expression in human neuronal cells (NT2-N)Chang-Jiang Guo, Steven D Douglas, Jian-Ping Lai, et al.
Journal of Translational Medicine|May 28, 2016
Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIVJeffrey S Barrett, Sergei Spitsin, Ganesh Moorthy, et al.
Current HIV Research|May 28, 2014
Modeling and simulation approach to support dosing and study design requirements for treating HIV-related neuropsychiatric disease with the NK1-R antagonist aprepitantJeffrey S Barrett, Gaurav Bajaj, Jennifer McGuire, et al.
Alcoholism, Clinical and Experimental Research|December 25, 2002
Alcohol potentiates HIV-1 infection of human blood mononuclear phagocytesXu Wang, Steven D Douglas, David S Metzger, et al.
The Pediatric Infectious Disease Journal|September 19, 2002
Efavirenz liquid formulation in human immunodeficiency virus-infected childrenStuart E Starr, Courtney V Fletcher, Stephen A Spector, et al.
Clinical and Diagnostic Laboratory Immunology|March 11, 2003
Assessment of thymic activity in human immunodeficiency virus-negative and -positive adolescents by real-time PCR quantitation of T-cell receptor rearrangement excision circlesThao Pham, Marvin Belzer, Joseph A Church, et al.
Alcoholism, Clinical and Experimental Research|October 6, 2005
Alcohol suppresses IL-2-induced CC chemokine production by natural killer cellsTing Zhang, Chang-Jiang Guo, Steven D Douglas, et al.
Clinical and Vaccine Immunology : CVI|September 15, 2006
Measurement of plasma-derived substance P: biological, methodological, and statistical considerationsDonald E Campbell, Nancy Raftery, Richard Tustin, et al.
Biological Psychiatry|October 20, 2007
Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndromeDwight L Evans, Kevin G Lynch, Tami Benton, et al.
Pageof 13

Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
AIDS (London, England)|October 3, 2003
Phase I/II trial of intravenous recombinant interleukin-2 in HIV-infected childrenStuart E Starr, Elizabeth J McFarland, Petronella Muresan, et al.
Journal of Neurochemistry|February 27, 2003
Interleukin-1beta stimulates macrophage inflammatory protein-1alpha and -1beta expression in human neuronal cells (NT2-N)Chang-Jiang Guo, Steven D Douglas, Jian-Ping Lai, et al.
Journal of Translational Medicine|May 28, 2016
Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIVJeffrey S Barrett, Sergei Spitsin, Ganesh Moorthy, et al.
Current HIV Research|May 28, 2014
Modeling and simulation approach to support dosing and study design requirements for treating HIV-related neuropsychiatric disease with the NK1-R antagonist aprepitantJeffrey S Barrett, Gaurav Bajaj, Jennifer McGuire, et al.
Alcoholism, Clinical and Experimental Research|December 25, 2002
Alcohol potentiates HIV-1 infection of human blood mononuclear phagocytesXu Wang, Steven D Douglas, David S Metzger, et al.
The Pediatric Infectious Disease Journal|September 19, 2002
Efavirenz liquid formulation in human immunodeficiency virus-infected childrenStuart E Starr, Courtney V Fletcher, Stephen A Spector, et al.
Clinical and Diagnostic Laboratory Immunology|March 11, 2003
Assessment of thymic activity in human immunodeficiency virus-negative and -positive adolescents by real-time PCR quantitation of T-cell receptor rearrangement excision circlesThao Pham, Marvin Belzer, Joseph A Church, et al.
Alcoholism, Clinical and Experimental Research|October 6, 2005
Alcohol suppresses IL-2-induced CC chemokine production by natural killer cellsTing Zhang, Chang-Jiang Guo, Steven D Douglas, et al.
Clinical and Vaccine Immunology : CVI|September 15, 2006
Measurement of plasma-derived substance P: biological, methodological, and statistical considerationsDonald E Campbell, Nancy Raftery, Richard Tustin, et al.
Biological Psychiatry|October 20, 2007
Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndromeDwight L Evans, Kevin G Lynch, Tami Benton, et al.
Pageof 13